Cue Biopharma downsizes to focus on autoimmune pipeline
Cue Biopharma has instituted strategic restructuring measures with a plan to focus on autoimmune programs and carry out a workforce…
Cue Biopharma has instituted strategic restructuring measures with a plan to focus on autoimmune programs and carry out a workforce…
Ariceum Therapeutics has initiated a Phase I trial for iodine-123 labelled ¹²³I-ATT001 in brain cancer patients, as the company eyes…
Inimmune has dosed the first subject in its Phase I clinical trial of INI-4001, an immunotherapeutic agent designed for treating…
Blue Earth Therapeutics has entered a clinical research partnership with University College London in the UK to progress the clinical…
Jaguar Health said an initial analysis of anti-diarrhoeal drug Mytesi (crofelemer) in cancer patients showed the Phase III trial did…
US-based biopharmaceutical company Nuvalent has dosed the first subject in a Phase Ia/IIb trial of NVL-330, a HER2-selective inhibitor designed…
IceCure Medical has reported data from three clinical trials, showcasing the efficacy of its ProSense cryoablation device in the treatment…
Lisata Therapeutics has partnered with Haystack Oncology, a Quest Diagnostics company, to use the latter’s minimal residual disease (MRD) test…
AVEO Oncology has announced a Phase III flop of its advanced metastatic renal cell carcinoma (RCC) combination therapy but has…
Bayer is set to pursue a label expansion for Nubeqa (darolutamide) in a distinct subgroup of prostate cancer patients—those with…